TABLE 1.
Baseline Characteristics of the Study Groupa
| Underlying Condition | n | Surgical Intervention | Type of NSAID | Duration of NSAID Before PRP Preparation, d |
|---|---|---|---|---|
| ACL rupture | 1 | ACL reconstruction | Dexibuprofen 400 mg twice daily | 3 |
| Gonarthrosis | 1 | Total knee endoprosthesis | Diclofenac 75 mg twice daily | 4 |
| Subacromial impingement | 3 | Arthroscopic subacromial decompression | Diclofenac 75 mg twice daily | 2 |
| Bony Bankart lesion of the shoulder | 1 | Open revision and screw fixation of the fragment | Dexibuprofen 400 mg twice daily | 3 |
| Rotator cuff tear | 3 | Arthroscopic rotator cuff repair | Dexibuprofen 400 mg twice daily | 2 |
| Postfemoral locking nail | 1 | Hardware removal | Diclofenac 75 mg twice daily | 5 |
| Chronic patellar dislocation | 1 | Tibial tubercle transfer | Diclofenac 75 mg twice daily | 2 |
aACL, anterior cruciate ligament; NSAID, nonsteroidal anti-inflammatory drug; PRP, platelet-rich plasma.